Table 2.
Dietary intake, food and energy efficiency, fasting plasma glucose, triglycerides, total and fractions cholesterol, and adipose tissues mass.
| Control | Obese | Obese+n7 | |
|---|---|---|---|
| Food ingestion (g/day/animal)–Period I | 4.40 ± 0.142 | 2.35 ± 0.037* | - |
| Food ingestion (g/day/animal)–Period II | 4.18 ± 0.10 | 2.10 ± 0.01* | 2.04 ± 0.02* |
| Food efficiency–Period I | 0.22 ± 0.003 | 1.35 ± 0.035* | - |
| Food efficiency–Period II | 0.164 ± 0.002 | 0.597 ± 0.004* | 0.471 ± 0.004*# |
| Energy efficiency–Period I | 0.059 ± 0.001 | 0.25 ± 0.007* | - |
| Energy efficiency–Period II | 0.043 ± 0.001 | 0.111 ± 0.001* | 0.088 ± 0.001*# |
| Glucose (mg/dL) | 205.28 ± 15.50 | 285.48 ± 36.03 | 282.77 ± 32.19 |
| Triglycerides (mg/dL) | 64.19 ± 3.37 | 82.88 ± 4.25* | 83.67 ± 3.72* |
| Total cholesterol (mg/dL) | 152.78 ± 4.83 | 200.56 ± 9.92* | 193.90 ± 6.57* |
| HDL cholesterol (mg/dL) | 74.67 ± 4.94 | 89.89 ± 3.09* | 92.97 ± 3.70* |
| LDL cholesterol (mg/dL) | 59.58 ± 4.72 | 90.49 ± 9.88* | 90.85 ± 7.68* |
| VLDL cholesterol (mg/dL) | 12.25 ± 0.79 | 16.56 ± 0.85* | 16.73 ± 0.74* |
| Subcutaneous (ING) mass (g) | 0.25 ± 0.05 | 1.12 ± 0.17* | 0.98 ± 0.08* |
| ING adipocytes diameter (μm) | 60.21 ± 1.89 | 81,90 ± 2.61* | 84.08 ± 1.97* |
| Epididymal mass (g) | 0.55 ± 0.04 | 1.60 ± 0.18* | 1.59 ± 0.11* |
| Retroperitoneal mass (g) | 0.12 ± 0.01 | 0.49 ± 0.04* | 0.52 ± 0.04* |
| Brown mass (g) | 0.07 ± 0.01 | 0.09 ± 0.01 | 0.09 ± 0.01 |
Dietary intake, energy and dietary efficiency per period. In the period I (week 1–4), the animals received control or high fat diet (Obese group). In the period II (week 4–8), the diets were maintained, and the animals received water (Control and Obese groups) or palmitoleic acid (Obese+n7 group) by oral gavage. Results were expressed as Mean ± SEM (n = 36). Data were analyzed by one way ANOVA.
*
p < 0.05 vs. Control,
#
p < 0.05 vs. Obese.